Clinical trial
Exploratory Trial of Interferon Alpha-2b in Neoadjuvant Treatment of Ocular Melanoma
NCT00621439 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Trial of Interferon Alpha-2b in Neoadjuvant Treatment of Ocular Melanoma
- Lead sponsor
- Emory University
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- March 31, 2007
- Completion date
- Not reported
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
ocular melanoma